The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia

Abstract Background Optimal anticoagulation strategy for cardiopulmonary bypass (CPB) in end-stage heart failure patients with heparin-induced thrombocytopenia (HIT) requiring left ventricular assist device (LVAD) implantation remains uncertain. Presently, there are no large-scale randomized studies...

Full description

Bibliographic Details
Main Authors: Yan K. Gernhofer, Michael Ross, Swapnil Khoche, Victor Pretorius
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Journal of Cardiothoracic Surgery
Subjects:
HIT
CPB
Online Access:http://link.springer.com/article/10.1186/s13019-018-0721-x